Henningfield JE - Search Results

1

Brave new world of tobacco disease prevention: promoting dual tobacco-product use?

Henningfield JE, Rose CA, Giovino GA. Henningfield JE, et al. Am J Prev Med. 2002 Oct;23(3):226-8. doi: 10.1016/s0749-3797(02)00502-0. Am J Prev Med. 2002. PMID: 12350457 No abstract available.

2

The tobacco endgame: it's all about behavior.

Henningfield JE. Henningfield JE. Prev Med. 2014 Nov;68:11-6. doi: 10.1016/j.ypmed.2014.09.003. Epub 2014 Sep 16. Prev Med. 2014. PMID: 25236479

3

A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004-2014.

Higgins ST, Kurti AN, Redner R, White TJ, Gaalema DE, Roberts ME, Doogan NJ, Tidey JW, Miller ME, Stanton CA, Henningfield JE, Atwood GS. Higgins ST, et al. Among authors: henningfield je. Prev Med. 2015 Nov;80:89-100. doi: 10.1016/j.ypmed.2015.06.009. Epub 2015 Jun 26. Prev Med. 2015. PMID: 26123717 Free PMC article. Review.

4

A pilot study of the use of smokeless tobacco.

Fant RV, Henningfield JE, Tomar SL. Fant RV, et al. Among authors: henningfield je. Am J Med. 1999 Aug;107(2):184-5. Am J Med. 1999. PMID: 10460055 No abstract available.

5

The scientific basis of tobacco product regulation.

Ashley DL, Burns D, Djordjevic M, Dybing E, Gray N, Hammond SK, Henningfield J, Jarvis M, Reddy KS, Robertson C, Zaatari G; WHO Study Group on Tobacco Product Regulation. Ashley DL, et al. World Health Organ Tech Rep Ser. 2008;(951):1-277, 1 p following 277. World Health Organ Tech Rep Ser. 2008. PMID: 19522165

6

Abuse liability assessment of tobacco products including potential reduced exposure products.

Carter LP, Stitzer ML, Henningfield JE, O'Connor RJ, Cummings KM, Hatsukami DK. Carter LP, et al. Among authors: henningfield je. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3241-62. doi: 10.1158/1055-9965.EPI-09-0948. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19959676 Free PMC article. Review.

7

Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.

Benowitz NL, Henningfield JE. Benowitz NL, et al. Among authors: henningfield je. Prev Med. 2018 Dec;117:5-7. doi: 10.1016/j.ypmed.2018.06.012. Epub 2018 Jun 23. Prev Med. 2018. PMID: 29944901

8

Tobacco product regulation: context and issues.

Slade J, Henningfield JE. Slade J, et al. Among authors: henningfield je. Food Drug Law J. 1998;53 suppl:43-74. Food Drug Law J. 1998. PMID: 10342980 No abstract available.

9

Tobacco addiction: implications for treatment and cancer prevention.

Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS. Cinciripini PM, et al. Among authors: henningfield je. J Natl Cancer Inst. 1997 Dec 17;89(24):1852-67. doi: 10.1093/jnci/89.24.1852. J Natl Cancer Inst. 1997. PMID: 9414173 Review.

10

The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Henningfield JE, Fant RV, Wang DW. Henningfield JE, et al. Psychopharmacology (Berl). 2018 Feb;235(2):573-589. doi: 10.1007/s00213-017-4813-4. Epub 2017 Dec 23. Psychopharmacology (Berl). 2018. PMID: 29273821 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results